Answers are grounded in this paper and cite their sources.
The success of an iCCM programme depends not only on increasing treatment coverage but addressing inequities in access to timely health care. Whilst much work is still needed to attain universal health care targets, and despite incomplete data, there is evidence that iCCM is successfully addressing treatment delays and targeting underserved populations.
No takes yet. Share an insight, caveat, or question.
Winskill et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: